Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cholesterol-13c2
2. 78887-48-6
3. Dtxsid00486648
4. Hy-n0322s5
5. Cs-0375988
6. Cholesterol-3,4-13c2, S & P Tested, 99 Atom % 13c
Molecular Weight | 388.6 g/mol |
---|---|
Molecular Formula | C27H46O |
XLogP3 | 8.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 5 |
Exact Mass | 388.361575757 g/mol |
Monoisotopic Mass | 388.361575757 g/mol |
Topological Polar Surface Area | 20.2 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 591 |
Isotope Atom Count | 2 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Cholesterol-3,4-13C2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cholesterol-3,4-13C2, including repackagers and relabelers. The FDA regulates Cholesterol-3,4-13C2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cholesterol-3,4-13C2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cholesterol-3,4-13C2 supplier is an individual or a company that provides Cholesterol-3,4-13C2 active pharmaceutical ingredient (API) or Cholesterol-3,4-13C2 finished formulations upon request. The Cholesterol-3,4-13C2 suppliers may include Cholesterol-3,4-13C2 API manufacturers, exporters, distributors and traders.
click here to find a list of Cholesterol-3,4-13C2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cholesterol-3,4-13C2 DMF (Drug Master File) is a document detailing the whole manufacturing process of Cholesterol-3,4-13C2 active pharmaceutical ingredient (API) in detail. Different forms of Cholesterol-3,4-13C2 DMFs exist exist since differing nations have different regulations, such as Cholesterol-3,4-13C2 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cholesterol-3,4-13C2 DMF submitted to regulatory agencies in the US is known as a USDMF. Cholesterol-3,4-13C2 USDMF includes data on Cholesterol-3,4-13C2's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cholesterol-3,4-13C2 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cholesterol-3,4-13C2 suppliers with USDMF on PharmaCompass.
Cholesterol-3,4-13C2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cholesterol-3,4-13C2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cholesterol-3,4-13C2 GMP manufacturer or Cholesterol-3,4-13C2 GMP API supplier for your needs.
A Cholesterol-3,4-13C2 CoA (Certificate of Analysis) is a formal document that attests to Cholesterol-3,4-13C2's compliance with Cholesterol-3,4-13C2 specifications and serves as a tool for batch-level quality control.
Cholesterol-3,4-13C2 CoA mostly includes findings from lab analyses of a specific batch. For each Cholesterol-3,4-13C2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cholesterol-3,4-13C2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Cholesterol-3,4-13C2 EP), Cholesterol-3,4-13C2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cholesterol-3,4-13C2 USP).
LOOKING FOR A SUPPLIER?